Article info
PDFEpidemiology
Original article
Impact of mass drug administration of azithromycin for trachoma elimination on prevalence and azithromycin resistance of genital Mycoplasma genitalium infection
- Correspondence to Dr Syed Tariq Sadiq, Applied Diagnostic Research and Evaluation Unit, St George's University of London, London SW17 0RE, UK; ssadiq{at}sgul.ac.uk
Citation
Impact of mass drug administration of azithromycin for trachoma elimination on prevalence and azithromycin resistance of genital Mycoplasma genitalium infection
Publication history
- Received December 14, 2018
- Revised March 14, 2019
- Accepted March 24, 2019
- First published April 13, 2019.
Online issue publication
October 17, 2019
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.